Alpha-tocopherol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
271 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 7 | 3 | 6 | 3 | 18 |
| Fatty liver | D005234 | EFO_0003934 | — | 1 | 7 | 2 | 6 | 3 | 18 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | 5 | 1 | 4 | 1 | 11 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 2 | 1 | 2 | 6 | 11 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | 1 | 2 | 3 | 8 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | 2 | — | 1 | 5 | 8 |
| Inflammation | D007249 | MP_0001845 | — | — | 2 | 1 | 1 | 4 | 7 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | 1 | 1 | 4 |
| Osteoradionecrosis | D010025 | EFO_1001821 | — | — | — | 1 | 1 | 2 | 4 |
| Infections | D007239 | EFO_0000544 | — | — | — | 2 | 1 | 1 | 4 |
Show 37 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Syndrome | D013577 | — | — | — | 6 | 4 | — | 6 | 15 |
| Fibrosis | D005355 | — | — | 1 | 5 | 3 | — | — | 8 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | — | 4 | 3 | — | 1 | 7 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | 1 | 1 | — | 3 | 6 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 1 | 1 | 1 | — | 3 | 6 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 1 | 3 | — | 1 | 6 |
| Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | 4 | 6 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | 2 | — | 1 | 6 |
| Osteonecrosis | D010020 | EFO_0004259 | M87 | — | 1 | 1 | — | 3 | 5 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | 2 | — | 1 | 5 |
Show 64 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | HP_0001903 | D64.9 | 2 | 2 | — | — | 3 | 6 |
| Asthma | D001249 | EFO_0000270 | J45 | 3 | 2 | — | — | 1 | 6 |
| Covid-19 | D000086382 | — | — | — | 2 | — | — | 3 | 5 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 2 | — | — | 2 | 4 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 2 | — | — | 1 | 3 |
| Mucositis | D052016 | EFO_1001898 | — | — | 1 | — | — | 2 | 3 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | — | 1 | — | — | 2 | 3 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | 2 | — | — | — | 2 |
| Pneumonia | D011014 | EFO_0003106 | — | — | 1 | — | — | 1 | 2 |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | — | 1 | — | — | 1 | 2 |
Show 61 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 3 | — | — | — | 5 | 8 |
| Iron deficiencies | D000090463 | — | — | 1 | — | — | — | 4 | 5 |
| Heart failure | D006333 | HP_0001635 | I50 | 3 | — | — | — | 1 | 4 |
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | 1 | — | — | — | 3 | 4 |
| Allergic rhinitis | D065631 | — | J30.9 | 2 | — | — | — | 1 | 3 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | — | — | 2 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | 1 | 2 |
| Fatigue | D005221 | HP_0012378 | R53.83 | 1 | — | — | — | 1 | 2 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | 1 | — | — | — | 1 | 2 |
| Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | — | 1 |
Show 6 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 4 | 4 |
| Alopecia | D000505 | HP_0002293 | L64 | — | — | — | — | 4 | 4 |
| Hypotrichosis | D007039 | HP_0008070 | — | — | — | — | — | 4 | 4 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 3 | 3 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 3 | 3 |
| Skin aging | D015595 | EFO_0005422 | — | — | — | — | — | 3 | 3 |
| Myalgia | D063806 | HP_0003326 | M79.1 | — | — | — | — | 2 | 2 |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | — | — | — | 2 | 2 |
| Thalassemia | D013789 | EFO_1001996 | D56 | — | — | — | — | 2 | 2 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 2 | 2 |
Show 87 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
37 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use